Related Experiment Videos
Statin Use Patterns among hypertensive Patients in a population-based study
Alireza Azarboo1, Yosef Farzi2, Mina Mirzad1
1Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Journal of Diabetes and Metabolic Disorders
|July 29, 2026
Summary
Statin use in Iranian hypertensive patients was low, despite high comorbidity rates. While statins showed a small association with reduced systolic blood pressure, they did not significantly improve overall hypertension control.
Area of Science:
- Cardiovascular disease research
- Public health surveillance
- Pharmacological interventions
Background:
- Limited understanding of statin utilization patterns in hypertension management at a population level.
- Previous research focused on cardiovascular risk and blood pressure reduction, not hypertension control.
- This study investigates statin use among Iranian hypertensive patients.
Purpose of the Study:
- To examine statin use patterns in relation to hypertension control among Iranian adults.
- To identify factors associated with statin use in hypertensive individuals.
- To assess the impact of statin use on blood pressure control in a large population sample.
Main Methods:
- Cross-sectional analysis of the 2021 WHO STEPwise approach to Non-communicable Disease Risk Factor Surveillance (STEPS) in Iran.
- Inclusion of 6,216 adult hypertensive patients (SBP ≥ 140 mmHg, DBP ≥ 90 mmHg, or on medication).
- Logistic and linear regression models to analyze associations between statin use, demographics, clinical factors, and blood pressure control.
Main Results:
- 29.2% of hypertensive patients used statins, predominantly older females.
- Statin use was linked to a significant 2.04 mmHg reduction in systolic blood pressure (SBP).
- No significant association was found between statin use and diastolic blood pressure or overall blood pressure control.
Conclusions:
- Statin use is low among Iranian hypertensive patients, highlighting a need for clinical attention.
- Further research, including clinical trials and cohort studies, is necessary to confirm the observed associations between statin use and blood pressure.
- Low statin utilization warrants further investigation in populations with high comorbidity burdens.
Related Concept Videos
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:28Hypertension I: Introduction
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...